NOT KNOWN FACTUAL STATEMENTS ABOUT CONOLIDINE

These final results, along with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 assist the strategy of targeting ACKR3 as a singular technique to modulate the opioid method, which could open up new therapeutic avenues for opioid-related Issues.Note: Success may well fluctuate about